“Efficacy of Rifaximin in Diarrhoea Predominant Irritable Bowel Syndrome: A Placebo Controlled Clinical Trial”. Medicine Today 35, no. 1 (April 13, 2023): 44–48. Accessed June 24, 2026. https://www.banglajol.info/index.php/MEDTODAY/article/view/64940.